Close Menu

NEW YORK – Exagen announced on Monday that it is collaborating with Emory University on a study to investigate the long-term effects of COVID-19 on the development of autoimmune diseases.

The longitudinal study will evaluate the emergence of biomarkers that are known indicators for the development of lupus, rheumatoid arthritis, and other autoimmune diseases, Exagen said in a statement. The study will determine the emergence of the biomarkers in mild and moderate COVID-19 patients, including patients treated with dexamethasone.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.